CVS Health Corporation $CVS Shares Sold by Farmers & Merchants Investments Inc.

Farmers & Merchants Investments Inc. lowered its holdings in shares of CVS Health Corporation (NYSE:CVS) by 6.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 249,736 shares of the pharmacy operator’s stock after selling 17,038 shares during the period. Farmers & Merchants Investments Inc.’s holdings in CVS Health were worth $18,828,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Cantor Fitzgerald Investment Advisors L.P. raised its holdings in CVS Health by 1.6% in the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after buying an additional 6,615 shares during the period. Aaron Wealth Advisors LLC increased its position in shares of CVS Health by 177.4% in the third quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after acquiring an additional 21,911 shares in the last quarter. Red Mountain Financial LLC purchased a new position in shares of CVS Health in the 2nd quarter valued at $293,000. Osaic Holdings Inc. lifted its holdings in shares of CVS Health by 18.4% during the 2nd quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock valued at $15,828,000 after acquiring an additional 35,809 shares in the last quarter. Finally, AE Wealth Management LLC increased its holdings in CVS Health by 607.5% in the 2nd quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock valued at $16,708,000 after purchasing an additional 207,984 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Up 0.4%

NYSE CVS opened at $79.96 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a one year low of $43.65 and a one year high of $85.15. The company has a 50-day simple moving average of $78.86 and a 200-day simple moving average of $73.11. The firm has a market capitalization of $101.50 billion, a PE ratio of 210.41, a price-to-earnings-growth ratio of 0.79 and a beta of 0.48.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on CVS. Raymond James Financial boosted their price objective on CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Truist Financial set a $100.00 price target on CVS Health in a report on Wednesday, December 10th. Argus lifted their price objective on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Finally, Leerink Partners boosted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $94.67.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.